Aim & Scope
Cancer care is changing quickly, but the benefits of new treatments still reach patients unevenly. The Journal of Clinical Oncology Medicine (JCOM) publishes clinical and translational research that helps oncologists choose, deliver and evaluate treatment well.
We want work that informs real decisions in cancer care, from trials and cohort studies to instructive case reports and careful reviews.
Scope
JCOM publishes original research articles, review articles, case reports and short communications in areas including, but not limited to:
- Medical, radiation and surgical oncology
- Haematological malignancies
- Targeted therapy and immunotherapy
- Biomarkers and precision oncology
- Cancer screening and early detection
- Supportive, palliative and survivorship care
- Paediatric and adolescent oncology
- Toxicity and management of treatment side effects
- Cancer epidemiology and prevention
- Oncology services and health systems
Peer Review
Every submission goes through double-blind peer review by at least two independent reviewers with expertise in the subject. The usual time from submission to first editorial decision is 12–14 weeks. See the Peer Review Policy for details.
Originality
All manuscripts are screened for similarity with iThenticate before they go to reviewers, as set out in the Plagiarism Policy.
Open Access and Licensing
JCOM is fully open access. Authors keep the copyright in their work, which is published under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Article Processing Charges
There is no Article Processing Charge. Journal of Clinical Oncology Medicine charges authors nothing at any stage of submission, peer review or publication.
